bioAffinity Technologies receives US patent allowance for lung cancer test

Go back to bioAffinity Technologies receives US patent allowance for lung cancer test
(NASDAQ: BIAF) Delayed: 0.70 -0.07 (9.09%)
Previous Close $0.77    52 Week High
Open $0.76    52 Week Low
Day High $0.77    P/E N/A 
Day Low $0.61    EPS
Volume 429,861       

(NASDAQ: BIAFW) Delayed: 0.10 --0 (-0%)
Previous Close $0.10    52 Week High
Open $0.10    52 Week Low
Day High $0.10    P/E N/A 
Day Low $0.10    EPS
Volume 2,056,626